Clinical Trial Update: A Post Marketing Survey Study to Evaluate the Safety and Effectiveness of Intelence

View source ↗

Summary

A completed post-marketing survey evaluating the safety and effectiveness of Intelence (etravirine) for patients with Acquired immunodeficiency syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Immunodeficiency Syndrome

Drugs mentioned

• Intelence (Etravirine)

Snippet

Sponsor: Janssen Korea, Ltd., Korea | Conditions: Acquired Immune Deficiency Syndrome | Status: COMPLETED